ZyVersa Therapeutics (ZVSA) Earnings Date, Estimates & Call Transcripts $3.85 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 19EstimatedActual EPS (May. 15) -$4.53 Missed By -$0.83 Consensus EPS (May. 15) -$3.70 Get ZyVersa Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ZVSA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueZVSA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ZVSA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. ZyVersa Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.54)($0.54)($0.54)Q2 20241($0.52)($0.52)($0.52)Q3 20241($0.58)($0.58)($0.58)Q4 20241($0.63)($0.63)($0.63)FY 20244($2.27)($2.27)($2.27)ZVSA Earnings Date and InformationZyVersa Therapeutics last announced its quarterly earnings results on May 15th, 2024. The reported ($4.53) EPS for the quarter, missing analysts' consensus estimates of ($3.70) by $0.83. ZyVersa Therapeutics has generated $0.00 earnings per share over the last year. Earnings for ZyVersa Therapeutics are expected to decrease in the coming year, from ($15.05) to ($25.45) per share. ZyVersa Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 19th, 2024 based off prior year's report dates.Read More ZyVersa Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/19/2024(Estimated)------- 5/15/2024Q1 2024($3.70)($4.53)($0.83)($4.53)--11/14/2023Q3 2023($56.00)($31.50)+$24.50($0.09)--8/21/2023Q2 2023-($1,459.50)($1,459.50)($3.50)--5/12/2023Q1 2023-($136.50)($136.50)($0.39)-- ZyVersa Therapeutics Earnings - Frequently Asked Questions When is ZyVersa Therapeutics's earnings date? ZyVersa Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 19th, 2024 based off last year's report dates. Learn more on ZVSA's earnings history. Did ZyVersa Therapeutics beat their earnings estimates last quarter? In the previous quarter, ZyVersa Therapeutics (NASDAQ:ZVSA) missed the analysts' consensus estimate of ($3.70) by $0.83 with a reported earnings per share (EPS) of ($4.53). Learn more on analysts' earnings estimate vs. ZVSA's actual earnings. How much profit does ZyVersa Therapeutics generate each year? ZyVersa Therapeutics (NASDAQ:ZVSA) has a recorded net income of -$98.30 million. ZVSA has generated $0.00 earnings per share over the last four quarters. What is ZyVersa Therapeutics's EPS forecast for next year? ZyVersa Therapeutics's earnings are expected to decrease from ($15.05) per share to ($25.45) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Vaxxinity Earnings Date Lumos Pharma Earnings Date Guardion Health Sciences Earnings Date Kintara Therapeutics Earnings Date Imunon Earnings Date Vaccinex Earnings Date Traws Pharma Earnings Date Monopar Therapeutics Earnings Date Eterna Therapeutics Earnings Date NeuroSense Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Leading Healthcare Provider Stock Soars on Earnings BeatViking Therapeutics: Pharma Stock Soars on Positive EarningsEarnings Season Sell-Off: Is This Tech Giant a Buy?Pharma Leader Beats on Earnings, But Shares FallSemiconductor Giant Posts Big Earnings Beat, but Shares Stay FlatIs This Industrial Stock a Buy After Recent Earnings Boost?Consumer Staple Stock's Q2 Earnings: Key Surprises and Challenges This page (NASDAQ:ZVSA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZVSA Stock Alerts